Eventide Asset Management - ROIVANT SCIENCES LTD ownership

ROIVANT SCIENCES LTD's ticker is and the CUSIP is G76279101. A total of 180 filers reported holding ROIVANT SCIENCES LTD in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 1.6%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of ROIVANT SCIENCES LTD
ValueSharesWeighting
Q3 2023$19,742,704
+15.9%
1,690,3000.0%0.36%
+23.3%
Q2 2023$17,038,224
+36.6%
1,690,3000.0%0.29%
+25.8%
Q1 2023$12,474,414
-7.6%
1,690,3000.0%0.23%
-13.9%
Q4 2022$13,505,497
+153.4%
1,690,3000.0%0.27%
+153.3%
Q3 2022$5,330,000
-20.9%
1,690,3000.0%0.10%
-27.1%
Q2 2022$6,738,000
-17.6%
1,690,3000.0%0.14%
+12.5%
Q1 2022$8,177,000
+22.0%
1,690,300
+141.5%
0.13%
+48.8%
Q4 2021$6,703,000700,0000.09%
Other shareholders
ROIVANT SCIENCES LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Founders Fund VI Management, LLC 1,119,489$13,075,63299.02%
Patient Square Capital LP 12,639,920$147,634,26681.13%
QVT Financial LP 112,541,536$1,314,485,14074.33%
Two Seas Capital LP 7,915,232$92,449,91018.59%
Octagon Capital Advisors LP 4,367,000$51,006,5607.84%
SB INVESTMENT ADVISERS (UK) LTD 73,031,667$853,009,8717.02%
Decheng Capital Management III (Cayman), LLC 1,459,700$17,049,2965.69%
Anchorage Capital Group, L.L.C. 4,832,642$56,445,2595.10%
Rubric Capital Management LP 10,500,000$122,640,0004.60%
Artia Global Partners LP 914,023$10,675,7894.44%
View complete list of ROIVANT SCIENCES LTD shareholders